• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[二酰甘油焦磷酸神经酰胺质量指标的发育过程]

[Developmental process of DGPPN quality indicators].

作者信息

Großimlinghaus I, Falkai P, Gaebel W, Janssen B, Reich-Erkelenz D, Wobrock T, Zielasek J

机构信息

Klinik und Poliklinik für Psychiatrie und Psychotherapie, LVR-Klinikum Düsseldorf, Medizinische Fakultät, Heinrich-Heine-Universität, Bergische Landstr. 2, 40629 Düsseldorf, Deutschland.

出版信息

Nervenarzt. 2013 Mar;84(3):350-65. doi: 10.1007/s00115-012-3705-4.

DOI:10.1007/s00115-012-3705-4
PMID:23494246
Abstract

BACKGROUND

Valid and feasible quality indicators can measure healthcare quality and show potential for improvement in care. The German Association for Psychiatry and Psychotherapy (DGPPN) has developed trans-sectoral quality indicator sets for four mental disorders with high prevalence (alcohol dependence, dementia, depression and schizophrenia).

MATERIAL AND METHOD

The DGPPN followed a structured multistage process and used guideline recommendations and the results of systematic evidence searches as the basis for the development of these quality indicators. This was followed by a structured consensus process for all quality indicators.

RESULTS

Four evidence and consensus-based, diagnosis-specific and trans-sectoral quality indicator sets have been developed.

CONCLUSION

It is possible to develop quality indicators on the basis of guideline recommendations. The implementation of the DGPPN quality indicators will play a crucial role in order to evaluate their utility and feasibility as quality measures for German mental healthcare.

摘要

背景

有效且可行的质量指标能够衡量医疗保健质量,并显示出护理改进的潜力。德国精神病学与心理治疗协会(DGPPN)针对四种高患病率的精神障碍(酒精依赖、痴呆、抑郁症和精神分裂症)制定了跨部门质量指标集。

材料与方法

DGPPN遵循结构化的多阶段流程,并将指南建议和系统证据检索结果作为制定这些质量指标的基础。随后对所有质量指标进行结构化的共识达成过程。

结果

已制定出四个基于证据和共识、针对特定诊断且跨部门的质量指标集。

结论

基于指南建议制定质量指标是可行的。DGPPN质量指标的实施对于评估其作为德国精神卫生保健质量衡量标准的效用和可行性将发挥关键作用。

相似文献

1
[Developmental process of DGPPN quality indicators].[二酰甘油焦磷酸神经酰胺质量指标的发育过程]
Nervenarzt. 2013 Mar;84(3):350-65. doi: 10.1007/s00115-012-3705-4.
2
[Guideline intentions of the German Society of Psychiatry, Psychotherapy and Nervous Diseases (DGPPN)].[德国精神病学、心理治疗与神经疾病学会(DGPPN)的指南意向]
Nervenarzt. 2010 Sep;81(9):1041-8. doi: 10.1007/s00115-010-3082-9.
3
[On quality indicators of the DGPPN].[关于德国精神心理疾病治疗与预防协会的质量指标]
Nervenarzt. 2013 Nov;84(11):1382-4. doi: 10.1007/s00115-013-3883-8.
4
[Assessment of quality indicators with routine data: Presentation of a feasibility test in ten specialist clinics for psychiatry and psychotherapy].[利用常规数据评估质量指标:在十家精神科和心理治疗专科诊所进行的可行性测试报告]
Nervenarzt. 2015 Nov;86(11):1393-9. doi: 10.1007/s00115-015-4357-y.
5
[Psychosocial interventions in severe mental illness: evidence and recommendations: psychoeducation, social skill training and exercise].[严重精神疾病的心理社会干预:证据与建议:心理教育、社交技能训练与运动]
Nervenarzt. 2012 Jul;83(7):847-54. doi: 10.1007/s00115-011-3471-8.
6
[Methodology of the S3 guidelines on alcohol and tobacco-related disorders].[S3酒精和烟草相关障碍指南的方法学]
Nervenarzt. 2016 Jan;87(1):6-12. doi: 10.1007/s00115-015-4377-7.
7
The "DGPPN-Cohort": A national collaboration initiative by the German Association for Psychiatry and Psychotherapy (DGPPN) for establishing a large-scale cohort of psychiatric patients.“DGPPN 队列研究”:德国精神病学与心理治疗协会(DGPPN)发起的一项全国性合作倡议,旨在建立一个大规模的精神科患者队列。
Eur Arch Psychiatry Clin Neurosci. 2013 Dec;263(8):695-701. doi: 10.1007/s00406-013-0401-8. Epub 2013 Apr 3.
8
[Comment on the S3 Guidelines Dementia by the DGPPN and the DGN from the neurological point of view].[德国神经病学专业协会和德国神经病学学会对痴呆症S3指南的神经学视角评论]
Fortschr Neurol Psychiatr. 2010 Sep;78(9):504-8. doi: 10.1055/s-0029-1245469. Epub 2010 Sep 8.
9
[DGPPN recommendations on quality indicators for schizophrenia].[精神分裂症质量指标的双相障碍工作组建议]
Nervenarzt. 2017 Jul;88(7):779-786. doi: 10.1007/s00115-017-0347-6.
10
[Mental comorbidities of alcohol-related disorders].[酒精相关障碍的精神共病]
Nervenarzt. 2016 Jan;87(1):26-34. doi: 10.1007/s00115-015-4378-6.

引用本文的文献

1
Regional variations in healthcare in people living with dementia in Germany: protocol for a mixed-methods study.德国痴呆症患者医疗保健的地区差异:一项混合方法研究的方案
BMJ Open. 2025 Feb 16;15(2):e092210. doi: 10.1136/bmjopen-2024-092210.
2
Developing quality indicators for cross-sectoral psycho-oncology in Germany: combining the RAND/UCLA appropriateness method with a Delphi technique.制定德国跨部门心理肿瘤学质量指标:结合 RAND/UCLA 适宜性方法和德尔菲技术。
BMC Health Serv Res. 2023 Jun 8;23(1):599. doi: 10.1186/s12913-023-09604-3.
3
[Frequency of coercive measures as a quality indicator for psychiatric hospitals?].

本文引用的文献

1
EPA guidance on the quality of mental health services.环境保护署关于心理健康服务质量的指南。
Eur Psychiatry. 2012 Feb;27(2):87-113. doi: 10.1016/j.eurpsy.2011.12.001. Epub 2012 Jan 20.
2
Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level.精神疾病患者的躯体疾病。二、照护、监测和治疗指南方面的障碍,以及系统和个体层面的建议。
World Psychiatry. 2011 Jun;10(2):138-51. doi: 10.1002/j.2051-5545.2011.tb00036.x.
3
Supervised disulfiram in the treatment of alcohol use disorder: a commentary.
[强制约束措施的使用频率能否作为精神病医院的一项质量指标?]
Nervenarzt. 2019 Jan;90(1):35-39. doi: 10.1007/s00115-018-0611-4.
4
The influence of cross-sectoral treatment models on patients with mental disorders in Germany: study protocol of a nationwide long-term evaluation study (EVA64).跨部门治疗模式对德国精神障碍患者的影响:一项全国范围长期评估研究(EVA64)的研究方案。
BMC Psychiatry. 2018 May 18;18(1):139. doi: 10.1186/s12888-018-1721-z.
5
Identifying primary care quality indicators for people with serious mental illness: a systematic review.确定严重精神疾病患者的初级保健质量指标:一项系统综述。
Br J Gen Pract. 2017 Aug;67(661):e519-e530. doi: 10.3399/bjgp17X691721. Epub 2017 Jul 3.
6
[DGPPN recommendations on quality indicators for schizophrenia].[精神分裂症质量指标的双相障碍工作组建议]
Nervenarzt. 2017 Jul;88(7):779-786. doi: 10.1007/s00115-017-0347-6.
7
[Voluntary and mandatory quality assurance in mental health care: European examples].[精神卫生保健中的自愿与强制质量保证:欧洲实例]
Nervenarzt. 2015 Nov;86(11):1326-32. doi: 10.1007/s00115-015-4334-5.
8
[Assessment of quality indicators with routine data: Presentation of a feasibility test in ten specialist clinics for psychiatry and psychotherapy].[利用常规数据评估质量指标:在十家精神科和心理治疗专科诊所进行的可行性测试报告]
Nervenarzt. 2015 Nov;86(11):1393-9. doi: 10.1007/s00115-015-4357-y.
监督使用双硫仑治疗酒精使用障碍:评论。
Alcohol Clin Exp Res. 2011 Oct;35(10):1732-6. doi: 10.1111/j.1530-0277.2011.01519.x. Epub 2011 May 13.
4
Family intervention for schizophrenia.精神分裂症的家庭干预
Cochrane Database Syst Rev. 2010 Dec 8(12):CD000088. doi: 10.1002/14651858.CD000088.pub2.
5
Psychoeducation for schizophrenia.精神分裂症的心理教育
Schizophr Bull. 2011 Jan;37(1):21-2. doi: 10.1093/schbul/sbq138. Epub 2010 Dec 8.
6
Measuring quality of mental health care: a review of initiatives and programs in selected countries.测量心理健康护理质量:对选定国家的举措和计划的综述。
Can J Psychiatry. 2010 Sep;55(9):539-48. doi: 10.1177/070674371005500902.
7
Relapse prevention in first-episode schizophrenia--maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia.首发精神分裂症的复发预防——基于前驱症状的早期干预的维持与间歇性药物治疗:德国精神分裂症研究网络内的一项随机对照试验结果。
J Clin Psychiatry. 2011 Feb;72(2):205-18. doi: 10.4088/JCP.09m05459yel. Epub 2010 Jun 29.
8
Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC).欧洲精神病学协会(EPA)发布的关于严重精神疾病患者心血管疾病和糖尿病的立场声明,得到了欧洲糖尿病研究协会(EASD)和欧洲心脏病学会(ESC)的支持。
Eur Psychiatry. 2009 Sep;24(6):412-24. doi: 10.1016/j.eurpsy.2009.01.005. Epub 2009 Aug 13.
9
Decision aids for people facing health treatment or screening decisions.为面临医疗治疗或筛查决策的人群提供的决策辅助工具。
Cochrane Database Syst Rev. 2009 Jul 8(3):CD001431. doi: 10.1002/14651858.CD001431.pub2.
10
Longitudinal rates of lobar atrophy in frontotemporal dementia, semantic dementia, and Alzheimer's disease.额颞叶痴呆、语义性痴呆和阿尔茨海默病患者脑叶萎缩的纵向速率。
Alzheimer Dis Assoc Disord. 2010 Jan-Mar;24(1):43-8. doi: 10.1097/WAD.0b013e3181a6f101.